Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for CompuMed Inc. (CMPD : OTC)

• Company Description    COMPUMED, INC. is a medical systems company engaged primarily in the application of computer technology to medicine. The main aspects of Co.'s business are (i) the licensing of its proprietary technology in the OsteoGramR, a bone density test that was developed by the Company as a means of aiding physicians in diagnosing and monitoring osteoporosis, (ii) the computer interpretation of electrocardiograms, (iii) TeleCor Services Division, which is engaged in transtelephonic cardiac event monitoring. Number of Employees:

• Price / Volume Information    Yesterday's Closing Price: $4.41 Daily Weekly Monthly 20 Day Moving Average: 1,933 shares Shares Outstanding: 1.33 (millions) Market Capitalization: $5.86 (millions) Beta: -0.35 52 Week High: $4.75 52 Week Low: $1.95 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 44.46% 44.71% 12 Week -1.18% -2.77% Year To Date 0.00% 0.00%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 5777 West Century Blvd. Suite 360 - Los Angeles,CA 90045 USA ph: 310-258-5000 fax: 310-645-5880 investorrelations@compumedinc.com http://www.compumedinc.com

• General Corporate Information    Officers Lee Keddie - Chief Executive Officer and President David W. Pointer - Chairman Laura Carroll - Chief Financial Officer and Corporate Secretary Loren Den Herder - Director Charles Gillman - Director Peer Information CompuMed Inc. (BJCT) CompuMed Inc. (CADMQ) CompuMed Inc. (APNO) CompuMed Inc. (UPDC) CompuMed Inc. (IMTIQ) CompuMed Inc. (CYGN) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED PRODUCTS Sector: Medical CUSIP: 204914501 SIC: 7374 Fiscal Year Fiscal Year End: September Last Reported Quarter: 09/01/25 Next Expected EPS Date: 02/10/26 Share - Related Items Shares Outstanding: 1.33 Most Recent Split Date: 5.00 (0.04:1) Beta: -0.35 Market Capitalization: $5.86 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 02/10/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 1.71 Price/Cash Flow: 6.40 Price / Sales: 0.78 EPS Growth vs. Year Ago Period: -850.00% vs. Previous Quarter: -475.00% Sales Growth vs. Year Ago Period: 25.26% vs. Previous Quarter: 2.17% ROE 12/31/25 - - 09/30/25 - -1.90 06/30/25 - 4.83 ROA 12/31/25 - - 09/30/25 - -1.29 06/30/25 - 3.33 Current Ratio 12/31/25 - - 09/30/25 - - 06/30/25 - 2.28 Quick Ratio 12/31/25 - - 09/30/25 - - 06/30/25 - 2.26 Operating Margin 12/31/25 - - 09/30/25 - -0.85 06/30/25 - 2.27 Net Margin 12/31/25 - - 09/30/25 - -0.85 06/30/25 - 2.27 Pre-Tax Margin 12/31/25 - - 09/30/25 - - 06/30/25 - 0.17 Book Value 12/31/25 - - 09/30/25 - - 06/30/25 - 2.58 Inventory Turnover 12/31/25 - - 09/30/25 - - 06/30/25 - 7.03 Debt-to-Equity 12/31/25 - - 09/30/25 - - 06/30/25 - 0.16 Debt-to-Capital 12/31/25 - - 09/30/25 - - 06/30/25 - 13.75

Powered by Zacks Investment Research ©